Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
iShares Core MSCI Total International Stock ETF (IXUS) Eyes Path to $113 Target

iShares Core MSCI Total International Stock ETF (IXUS) Eyes Path to $113 Target

Key Takeaways

  • The $113 target is not an analyst consensus on the ETF itself. Because IXUS is an exchange-traded fund, the figure is drawn from publicly reported analyst price targets aggregated across roughly 3,340 stocks the fund holds, as compiled by TipRanks.
  • That aggregate average price target is about $112.94, with a reported range from roughly $97 (low) to $132 (high) across holdings, indicating a wide spread of opinion.
  • With IXUS recently trading around $96.20, reaching $113 would require a gain of roughly 17% — a substantial move rather than a modest drift.
  • The strongest supporting factors are a weaker U.S. dollar, a valuation discount versus the S&P 500, and a rotation into value and international cyclicals.
  • The biggest risks are dollar strength, geopolitical tensions, and the fund's heavy tilt toward cyclical sectors and its meaningful Canadian and Asian exposure.
  • You can explore more about this ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages for deeper context.
  • For a data-driven view of shifting market conditions across thousands of securities, explore Trending AI Robots.

How the $113 Objective Emerged from Underlying Holdings

IXUS is a passive ETF, not an individual stock, so it does not carry its own Wall Street price targets. Instead, the $113 figure comes from public market data aggregating analyst price targets for the individual companies inside the fund. TipRanks reports an average 12-month price target of about $112.94 derived from analyst targets on roughly 3,340 of the fund's holdings, with a low forecast near $97 and a high forecast near $132. The rounded central objective of $113 therefore reflects the collective view of sell-side analysts on the fund's underlying constituents — not a direct recommendation on the ETF. Notably, the underlying ratings skew constructive, with far more buy than sell ratings across the holdings, though the wide range signals genuine disagreement about how far international equities can climb. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where IXUS Stands Today and the Road Ahead

IXUS recently traded near $96.20, close to its 52-week high. Reaching $113 implies upside of about 17%, a substantial move that would require sustained gains across developed and emerging markets rather than a single catalyst. The fund tracks the MSCI ACWI ex USA IMI Index, giving investors exposure to large-, mid-, and small-cap companies outside the United States across roughly 4,000-plus holdings. Because the portfolio is so broad, the path to higher prices depends primarily on macroeconomic forces — above all the direction of the U.S. dollar, global growth, and relative valuations — rather than any single company's earnings.

Factors That Could Drive Gains Toward the Target

Several factors have powered international equities and could support further gains. A declining dollar boosts returns for U.S. investors holding foreign stocks, since overseas earnings translate into more dollars. International stocks also trade at a meaningful valuation discount: the fund's holdings carry a trailing P/E ratio in the high teens, well below the S&P 500's mid-20s multiple. Rotation out of expensive U.S. technology into cheaper value and cyclical names has favored the fund, and economic growth forecasts remain higher in several regions the fund covers. The fund's top holdings — including Taiwan Semiconductor Manufacturing, Samsung, ASML, Tencent, Novo Nordisk, HSBC, and Royal Bank of Canada — span semiconductors, financials, and healthcare, giving it exposure to global growth themes at a low 0.07% expense ratio.

Key Risks That Could Hold the Target at Bay

The principal obstacle is the U.S. dollar. If the dollar strengthens — on renewed inflation concerns, higher Federal Reserve rates, or geopolitical shocks — the currency tailwind that drove much of 2025's outperformance could reverse. The fund also carries heavy exposure to cyclical sectors such as financials, industrials, and materials, which makes it more volatile in an economic downturn, and its information-technology allocation is only about half that of the S&P 500, limiting AI-related upside. Geopolitical tensions, trade disputes, and a slowdown in key markets like Europe or China could weigh on the portfolio, while concentration in Canada among the top holdings adds idiosyncratic risk tied to Canadian banks and housing.

Technical Picture and Market Structure

IXUS has been in an established uptrend, with shares near the upper end of a 52-week range that extends from roughly $74 to just under $98. The area around $98 represents near-term resistance tied to prior highs, and a decisive close above that zone would open the next leg higher toward round-number levels. On the downside, the $92–$93 area and the psychological $90 level mark key support zones. Because the fund is broad-based and diversified, its price action tends to track the underlying MSCI index closely, making technical signals on the index — rather than the ETF itself — the more meaningful guide.

Time Horizon and Areas Worth Watching

The $113 objective is rooted in 12-month analyst price targets on the fund's holdings, so it reflects a research horizon of roughly one year rather than a short-term trade. Investors should watch the DXY dollar index, Federal Reserve and European Central Bank policy signals, global manufacturing data, and quarterly earnings from the fund's largest constituents. Fund flows into and out of international ETFs, along with any shifts in country or sector weightings, are also worth monitoring, as are developments in China's regulatory environment and Canada's banking sector. From what I see, this is important because macro shifts can move the fund faster than individual stock news.

Using AI Daily Buy/Sell Signals for Broader Context

In my analysis of funds like this, Tickeron's AI Daily Buy/Sell Signals provide a helpful layer by applying artificial intelligence to monitor thousands of stocks and ETFs in real time. The system generates Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a diversified fund like IXUS, where macro and currency trends often matter more than single-company catalysts, these signals can highlight momentum changes efficiently. I find them useful for spotting emerging trends across broad portfolios without having to scan everything manually.

Final Assessment

Can IXUS reach $113? The objective is grounded in a substantial, roughly 17% move from current levels, derived from analyst targets on the fund's underlying holdings rather than a direct ETF consensus. Supportive forces — a weaker dollar, a persistent valuation discount, and rotation into value and international cyclicals — have been powerful but are not guaranteed to persist. The clearest obstacles are dollar strength and the fund's cyclical, geographically concentrated exposure. With the underlying analyst range spanning from roughly $97 to $132, opinions differ widely. Investors should treat $113 as a benchmark for what holdings-level analyst expectations imply, not a forecast, and watch currency markets, global growth, and the fund's largest holdings for the next directional clues. I'm watching this closely as the dollar and growth data evolve.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IXUS

IXUS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IXUS turned positive on October 28, 2026. Looking at past instances where IXUS's MACD turned positive, the stock continued to rise in 42 of 45 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +1.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXUS advanced for three days, in 285 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 59 cases where IXUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IXUS as a result. In 65 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

IXUS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IXUS crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for IXUS entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are ConocoPhillips (NYSE:COP), Spotify Technology SA (NYSE:SPOT), Canadian Natural Resources Limited (NYSE:CNQ), PDD Holdings (NASDAQ:PDD), Suncor Energy (NYSE:SU), Wheaton Precious Metals Corp (NYSE:WPM), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Nokia Corp (NYSE:NOK), Nebius Group N.V. (NASDAQ:NBIS), ON Semiconductor Corp (NASDAQ:ON).

Industry description

The investment seeks to track the investment results of the MSCI ACWI ex USA IMI composed of large-, mid- and small-capitalization non-U.S. equities. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization weighted index designed to measure the combined equity market performance of developed and emerging markets countries, excluding the United States.

Market Cap

The average market capitalization across the iShares Core MSCI Total International Stock ETF (IXUS) ETF is 27.4B. The market cap for tickers in the group ranges from 219.02M to 185.04B. COP holds the highest valuation in this group at 185.04B. The lowest valued company is SAR at 219.02M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Core MSCI Total International Stock ETF (IXUS) ETF was 63%. For the same ETF, the average monthly price growth was 115%, and the average quarterly price growth was 213%. LEGN experienced the highest price growth at 12%, while XP experienced the biggest fall at -53%.

Volume

The average weekly volume growth across all stocks in the iShares Core MSCI Total International Stock ETF (IXUS) ETF was 15%. For the same stocks of the ETF, the average monthly volume growth was 6% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 59
Price Growth Rating: 53
SMR Rating: 61
Profit Risk Rating: 68
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
IXUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Category
Foreign Large Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.
iShares Core MSCI Total International Stock ETF (IXUS) Eyes Path to $113 Target